Teachers Advisors’s vTv Therapeutics VTVT Stock Holding History

Teachers Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-211	Closed	-$51K	–	3047
2017 Q4	$51K	Hold	211	–	–	﹤0.01%	3033
2017 Q3	$50K	Hold	211	–	–	﹤0.01%	3053
2017 Q2	$42K	Buy	211 +67	+47%	+$14K	﹤0.01%	3083
2017 Q1	$38K	Hold	144	–	–	﹤0.01%	3037
2016 Q4	$28K	Hold	144	–	–	﹤0.01%	3070
2016 Q3	$42K	Hold	144	–	–	﹤0.01%	3050
2016 Q2	$34K	Sell	144 -22	-13%	-$5.06K	﹤0.01%	3080
2016 Q1	$34K	Hold	166	–	–	﹤0.01%	3017
2015 Q4	$45K	Buy	+166	New	+$46.6K	﹤0.01%	3070

Other funds holding VTVT

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's VTVT Position: Q1 2018 in Review

Teachers Advisors sold out of vTv Therapeutics (VTVT) in Q1 2018, closing a stake of 211 shares — an estimated $51K sold.

Teachers Advisors first reported a position in VTVT in Q4 2015 and held it in 9 quarters. The position peaked at $51K in Q4 2017. 41 funds tracked by Wall St. Rank hold VTVT as of Q1 2018.

Teachers Advisors reported no remaining vTv Therapeutics position as of Q1 2018 after selling out during the quarter.
Teachers Advisors sold 211 vTv Therapeutics shares in Q1 2018, an estimated $51K.
Teachers Advisors first reported a position in vTv Therapeutics in Q4 2015 and held it in 9 quarters.
Teachers Advisors's vTv Therapeutics position peaked at $51K in Q4 2017.
41 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2018.

Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.